Atul Pande - 01 Feb 2022 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Feb 2022
Net transactions value
-$237,000
Form type
4
Filing time
02 Feb 2022, 15:08:56 UTC
Previous filing
12 Jan 2022
Next filing
16 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $40,000 +2,500 $16.00* 2,500 01 Feb 2022 Direct
transaction KRTX Common Stock Sale $277,000 -2,500 -100% $110.80 0 01 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -2,500 -100% $0.000000* 0 01 Feb 2022 Common Stock 2,500 $16.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2021.